Our weekend morning emails feature the very best news and exclusive content from our team of reporters An 'adored' ...

An archaeological investigation has revealed that a monument on Bodmin Moor was constructed more than 5,000 years ago. The ...

Cornwall, England’s craggy southwestern tip ... a stony beach where visitors can swim and explore the rock pools. Right: A room at the Gurnard’s Head, a dining pub with rooms on a remote ...

A military base in Cornwall is the subject of a redevelopment worth almost £100m, according to the Ministry of Defence (MoD). The project will see the rebuilding of Royal Naval Air Station ...

The village is particularly well placed for easy travelling to spectacular stretches of both the north and south Cornwall coastline. The village derives its' name from the remarkable mass of rock and ...

Rock Oyster festival has today revealed three headliners ... 2025 in the grounds of the stunning Dinham House right on the banks of the Camel Estuary in Cornwall. Ministry of Sound Classical, ...

Roche CEO: not good to limit competition in this space Roche says not itself, but others affected by Catalent deal Swiss drugmaker joins US peer Lilly in voicing opposition Eli Lilly and advocacy ...

Rappers Eminem and Kid Rock have taken opposing sides in the lead-up to the 2024 presidential election, setting the stage for a political showdown between the two Michigan-born stars. With ...

Speaking to the press Wednesday, Roche’s chief executive Thomas Schinecker critiqued the proposed transaction, arguing that it could hamper the ability of smaller biopharma players to lock down ...

Swiss Pharmaceutical giant Roche Holding (OTCQX:RHHBY) (OTCQX:RHHBF) on Wednesday reaffirmed its full-year sales and earnings outlook after the company’s third-quarter sales results exceeded ...

Roche doesn’t think so. “I think we don’t see anything that should be slowing Vabysmo momentum down,” Teresa Graham, CEO of Roche Pharmaceuticals, said during a press conference Wednesday ...

Roche ROG-1.53%decrease; red down pointing triangle confirmed its profit outlook for the year after its eye drug Vabysmo, multiple-sclerosis treatment Ocrevus and hemophilia injection Hemlibra ...